Cimifugin

Saposhnikovia divaricata

Interstellar grade B

Preclinical: Mechanistic, cell or animal evidence. No single preclinical driver opens a pathway on its own.

Appears on 1 blend page, linked below.

In liver cells injured by saturated fat, cimifugin reversed the damage through TLR4, the receptor that turns fat into inflammation.

Where it appears

One blend page carries this ingredient. Open it and you will find this ingredient in the list.

• Ceramide Blocker (Lipotoxicity Neutralizer)